No Detail Found!

Incidence and Trend of Liver Cancer in Iran.

Author(s)
Maryam Mirzaei Department of Epidemiology, Tabriz University of Medical Sciences, Tabriz, Iran
Mahshid Ghoncheh Department of Epidemiology and Biostatistics, Hamadan University of Medical Sciences, Hamadan, Iran
Zahra Pournamdar Pregnancy Health Research Center, Zahedan University of Medical Sciences, Zahedan, Iran
Fahimeh Soheilipour Minimally Invasive Surgery Research Center, Tehran University of Medical Sciences, Tehran, Iran
Hamid Salehiniya Epidemiology, and Biostatistics5, Tehran University of Medical Sciences, Tehran, Iran
Abstract
Objective: To determine incidence and trend of the liver cancer in Iran. Study Design: An observational study. Place and Duration of Study: The Cancer Registry System in Iran, from 2003 to 2009. Methodology: Crude incidence rate for liver cancer were calculated per 100,000 people. Age standardized incidence rates (ASRs) were estimated using direct standardization and the standard population of World Health Organization (WHO). Data was analyzed using Cochran-Armitage test for linear trend and software of WinPepi 2.1. Results: Of 3,584 cases of liver cancer recorded between 2003 and 2009, 2,224 and 1,360 cases were men and women, respectively, which revealed significantly increasing trends (p=0.001). The highest incidence rate (950 cases) occurred in 2007 and the lowest rate (256 cases) in 2003. Based on the result, liver cancer incidence was more in men compared to women and the incidence increased with age. Conclusion: According to this study, the trend of age-standardized incidence rate of liver cancer in Iran is rising. Hence to prevent and control this cancer, it is necessary to investigate the related risk factors and implement prevention programs in Iran.
Publication Details
Page(s) 306-309
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 26, Issue: 4, Year: 2016

Request the full text from PASTIC

References
KeyghobadiN,RafiemaneshH,Mohammadian-HafshejaniA,EnayatradM,Salehiniya H, 2015.Epidemiology and trend of cancers in the province of Kerman: Southeast of Iran,APJCP 16 1409 -13
FerlayJ,SoerjomataramI,DikshitR,EserS,MathersC,RebeloM, 2015.Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012,Int J Cancer 136 E359 -86
MousaviSM,GouyaMM,RamazaniR, 2009.Cancer incidence and mortality in Iran,Ann Oncol 20 556 -63
ChengY,SuMX,LiD,ZhaoGZ,GaoH, 2012.Bicluster and pathway enrichment analysis of HCV-induced cirrhosis and hepatocellular carcinoma,APJCP 13 3741 -5
FanJH,WangJB,JiangY,XiangW,LiangH,WeiWQ, 2013.Attributable causes of liver cancer mortality and incidence in china,APJCP 14 7251 -6
HajianiE,MasjedizadehR,HashemiJ,AzmiM,RajabiT, 2005.Risk factors for hepatocellular carcinoma in Southern Iran,Saudi Med J 26 974 -7
LafaroKJ,DemirjianAN,PawlikTM, 2015.Epidemiology of hepatocellular carcinoma,Surg Oncol Clin N Am 24 1 -17
NordenstedtH,WhiteDL,El-SeragHB, 2010.The changing pattern of epidemiology in hepatocellular carcinoma. Digestive and liver disease,Dig Liver Dis 42 S206 -14
FarahmandM,Almasi-HashianiA,FallahzadeMH, 2013.Epidemiology of cancer of liver and intrahepatic bile ducts based on fars province cancer registry's data (,ZJRMS 15 86 -9
AbdelazizAO,ElbazTM,ShoushaHI,IbrahimMM,Rahman El-ShazliMA,AbdelmaksoudAH, 2014.Survival and prognostic factors for hepatocellular carcinoma: an Egyptian multidisciplinary clinic experience,APJCP 15 3915 -20
AlavianSM,FallahianF,LankaraniKB, 2007.The changing epidemiology of viral hepatitis B in Iran,JGLD 16 403 -6
MoghaddamSD,HaghdoostAA,HoseiniSH,RamazaniR,RezazadehkermaniM., 2010.Incidence of hepatocellular carcinoma in southeast iran,Hepat Mon 10 270 -4
ParkinDM,BrayF,FerlayJ,PisaniP, 2005.,2002. CA Cancer J Clin 55 74 -108
FerlayJ,ShinHR,BrayF,FormanD,MathersC,ParkinDM, 2010.Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008,Int J Cancer 127 2893 -917
YeoleBB, 2008.Trends in cancer incidence in esophagus, stomach, colon, rectum and liver in males in India,APJCP 9 97 -100
WiangnonS,Kamsa-ardS,SuwanrungruangK,PromthetS,Kamsa-ardS,MahaweerawatS,KhonKaen,Thailand. APJCP, 2012.Trends in incidence of hepatocellular carcinoma,, 13 1065 -8
LukeC,PriceT,RoderD., 2010.Epidemiology of cancer of the liver and intrahepatic bile ducts in an Australian population,APJCP 11 1479 -85
Norsa'adahB,Nurhazalini-ZayaniCG, 2013.Epidemiology and survival of hepatocellular carcinoma in north-east Peninsular Malaysia,APJCP 14 6955 -9
SadjadiA,ZahediM,NouraieM,AlimohammadianM,GhorbaniA,BahmanyarS, .The first population-based, -
YuanJM,RossRK,StanczyFZ,GovindarajanS,GaoYT,HendersonBE, 1995.A cohort study of serum testosterone and hepatocellular carcinoma in Shanghai, China,Int J Cancer 63 491 -3
BabaeiM,MousaviS,MalekM,TosiG,MasoumehZ,DanaeiN, 2005.Cancer occurrence in Semnan province, Iran: results of a population-based cancer registry,APJCP 6 159 -64
SadjadiA,MalekzadehR,DerakhshanMH,SepehrA,NouraieM,SotoudehM, 2003.Cancer occurrence in Ardabil: Results of a population-based cancer registry from Iran,Int J Cancer 107 113 -8
GanjiA,SafaviM,NouraieS,Nasseri-MoghadamS,MeratS,VahediH, 2006.Digestive and liver diseases statistics in several referral,Govaresh 11 33 -8
RaziS,EnayatradM,Mohammadian-HafshejaniA,SalehiniyaH,Fathali-Loy-DizajiM,SoltaniS., 2015.The epidemiology of skin cancer and its trend in Iran,Int J Prevent Med 6 64 -
PoustchiH,SepanlouS,EsmailiS,MehrabiN,AnsarymoghadamA, 2010.Hepatocellular carcinoma in the world and the middle East,Middle East J Dig Dis 2 31 -41
0

Citations

0

Downloads

65

Views